Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.39 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10592933 | 0.95 | THRA (0.55) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL2818976 | 0.93 | THRA (0.57) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL678039 | 0.93 | THRA (0.57) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL2817615 | 0.93 | THRA (0.57) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL23535276 | 0.92 | THRA (0.56) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL2817838 | 0.89 | PPARD (0.43) | THRATHRBLTB4RLTB4R2PPARD | |
| SCHEMBL2817841 | 0.88 | THRA (0.47) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL617425 | 0.87 | ALOX5 (0.48) | THRATHRBALOX5PTGS2PPARA | |
| SCHEMBL2822983 | 0.83 | L3MBTL1 (0.48) | — | |
| SCHEMBL10592927 | 0.83 | THRA (0.52) | THRATHRBALOX5PTGS2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8604233-B2 | Lubricant composition, magnetic recording medium, and novel polyether compound | FUJIFILM CORPORATION (JP) | 2013-12-10 | — | — | US | disclosed |
| US-7812171-B2 | Black pigment, black pigment dispersion and black resin composition comprising the same | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-7612148-B2 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2009-11-03 | — | — | US | disclosed |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20080146733-A1 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | MUC1, NEFM, CA13 | THRA 3283/4885THRB 4279/4885ALOX5 211/4885 |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | DYNLL1, HNRNPL, AOX1 | THRA 4295/4885THRB 4570/4885ALOX5 116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.